Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (2553)	11/17/1997 9:43:00 AM
From: Cacaito	Read Replies (2) \| Respond to of 23519

National Awareness Month continues:Zona agreement with Schering-Plough just out on prnewswire get ready to see if the "expanding ED market" brings Vivus down again. Still holding but no margin.

To: James Baker who wrote (2553)	11/17/1997 6:36:00 PM
From: Bradpalm1	Read Replies (1) \| Respond to of 23519

Jim, At the risk of sounding like a broken record, the announcement of UK approval REMAINS on the near-term horizon although its exact timing remains anybody's guess. Other POSITIVE NEWS should follow in the weeks ahead which should re-establish Vivus in the minds of the investing public as a legitimate major player in the field of ED. As you know, I'm not a cheerleader for Vivus and I still question its value as a longterm investment for reasons I wont go into. However, I'm a student of the ED and still consider Muse (the delivery system) to be tremendous conceptual product with still unfulfilled potential. From a purely medical standpoint, a thriving, innovative, and successful Vivus can only further our understanding and capabilities for the future treatment of ED. Good news is therefore good news anyway you slice it. I continue to hear conflicting information about Zonagen and the data from the clinical trials for Vasomax (oral phentolamine). Today's agreement with SGP (the least ethical of all major pharmaceutical companies) appeared half-hearted and speculative. Does anybody have further insights or information about Zonagen and this agreement with SGP? I think that this company has something to hide. Bradpalm1 P.S. Toyko VD: read your e-mail!